DG
BMY icon

Davidson & Garrard’s Bristol-Myers Squibb BMY Stock Holding History

Davidson & Garrard’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$2.85M Sell
44,763
-3,720
-8% -$217K 0.67% 54
2017
Q2 		$2.7M Sell
48,483
-2,757
-5% -$150K 0.64% 56
2017
Q1 		$2.79M Sell
51,240
-598
-1% -$32.8K 0.66% 56
2016
Q4 		$3.03M Sell
51,838
-2,410
-4% -$132K 0.75% 52
2016
Q3 		$2.92M Buy
54,248
+7,817
+17% +$502K 0.73% 51
2016
Q2 		$3.42M Sell
46,431
-475
-1% -$33.6K 0.84% 44
2016
Q1 		$3M Sell
46,906
-572
-1% -$36.1K 0.77% 50
2015
Q4 		$3.27M Sell
47,478
-1,135
-2% -$75K 0.81% 45
2015
Q3 		$2.88M Buy
48,613
+2,225
+5% +$141K 0.75% 53
2015
Q2 		$3.09M Sell
46,388
-140
-0.3% -$9.23K 0.72% 52
2015
Q1 		$3M Sell
46,528
-869
-2% -$54.4K 0.68% 57
2014
Q4 		$2.8M Sell
47,397
-1,491
-3% -$84.1K 0.65% 59
2014
Q3 		$2.5M Sell
48,888
-17,785
-27% -$888K 0.61% 65
2014
Q2 		$3.23M Sell
66,673
-293
-0.4% -$14.4K 0.78% 50
2014
Q1 		$3.48M Sell
66,966
-298
-0.4% -$15.9K 0.87% 46
2013
Q4 		$3.58M Sell
67,264
-1,742
-3% -$88.7K 0.91% 43
2013
Q3 		$3.19M Buy
69,006
+174
+0.3% +$7.64K 0.9% 45
2013
Q2 		$3.08M Buy
+68,832
New +$2.99M 0.92% 45

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Davidson & Garrard's BMY Position: Q3 2017 in Review

Davidson & Garrard reduced its Bristol-Myers Squibb (BMY) stake by 7.7% in Q3 2017, selling an estimated $217K and leaving 44,763 shares worth $2.85M. The position accounts for 0.67% of the portfolio, ranked #54.

Davidson & Garrard first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. The position peaked at $3.58M in Q4 2013. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Davidson & Garrard held 44,763 shares of Bristol-Myers Squibb worth $2.85M as of Q3 2017.
  • Davidson & Garrard sold 3,720 Bristol-Myers Squibb shares in Q3 2017, an estimated $217K.
  • Bristol-Myers Squibb made up 0.67% of Davidson & Garrard's portfolio in Q3 2017, its #54 holding.
  • Davidson & Garrard first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
  • Davidson & Garrard's Bristol-Myers Squibb position peaked at $3.58M in Q4 2013.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.